ArticleFrontiers in oncology2022

Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate.

Taotao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.